Global Folic Acid Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Folic Acid Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Folic Acid Injection is a sterile, nonpyrogenic solution of sodium folate prepared by the addition of sodium hydroxide to folic acid in Water for Injection intended for intramuscular, intravenous or subcutaneous use. Folic acid is a B-complex vitamin needed to form healthy cells, especially red blood cells. Folic acid is used to treat or prevent certain anemias caused by poor diet, pregnancy, alcoholism, liver disease, certain stomach/intestinal problems, kidney dialysis, or other conditions.
Folic Acid Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Folic Acid Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Elderly and Children are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Folic Acid Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Folic Acid Injection key manufacturers include Merck & Co, Eli Lilly, Sandoz Canada Incorporated, Ceva Animal Health Australia, Shanghai Pharmaceuticals and Anhui Medipharm, etc. Merck & Co, Eli Lilly, Sandoz Canada Incorporated are top 3 players and held % sales share in total in 2022.
Folic Acid Injection can be divided into Folic Acid Inj 5mg/ml and Folic Acid Inj 30mg/2ml, etc. Folic Acid Inj 5mg/ml is the mainstream product in the market, accounting for % sales share globally in 2022.
Folic Acid Injection is widely used in various fields, such as Elderly, Children and Adult,, etc. Elderly provides greatest supports to the Folic Acid Injection industry development. In 2022, global % sales of Folic Acid Injection went into Elderly filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Folic Acid Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Merck & Co
Eli Lilly
Sandoz Canada Incorporated
Ceva Animal Health Australia
Shanghai Pharmaceuticals
Anhui Medipharm
Segment by Type
Folic Acid Inj 5mg/ml
Folic Acid Inj 30mg/2ml
Elderly
Children
Adult
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Folic Acid Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Folic Acid Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Folic Acid Injection industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Folic Acid Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Folic Acid Injection introduction, etc. Folic Acid Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Folic Acid Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Folic Acid Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Folic Acid Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Elderly and Children are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Folic Acid Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Folic Acid Injection key manufacturers include Merck & Co, Eli Lilly, Sandoz Canada Incorporated, Ceva Animal Health Australia, Shanghai Pharmaceuticals and Anhui Medipharm, etc. Merck & Co, Eli Lilly, Sandoz Canada Incorporated are top 3 players and held % sales share in total in 2022.
Folic Acid Injection can be divided into Folic Acid Inj 5mg/ml and Folic Acid Inj 30mg/2ml, etc. Folic Acid Inj 5mg/ml is the mainstream product in the market, accounting for % sales share globally in 2022.
Folic Acid Injection is widely used in various fields, such as Elderly, Children and Adult,, etc. Elderly provides greatest supports to the Folic Acid Injection industry development. In 2022, global % sales of Folic Acid Injection went into Elderly filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Folic Acid Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Merck & Co
Eli Lilly
Sandoz Canada Incorporated
Ceva Animal Health Australia
Shanghai Pharmaceuticals
Anhui Medipharm
Segment by Type
Folic Acid Inj 5mg/ml
Folic Acid Inj 30mg/2ml
Segment by Application
Elderly
Children
Adult
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Folic Acid Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Folic Acid Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Folic Acid Injection industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Folic Acid Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Folic Acid Injection introduction, etc. Folic Acid Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Folic Acid Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.